2BBBullish & Bearish
Haemonetics Corporation Common Stock (HAE) trades on NYSE. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 59 out of 100.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s. Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.
Haemonetics Corporation Common Stock’s current 2BB score is 59 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 72 | High |
| Momentum | 60 | Improving |
| Financial strength | 68 | Strong |
| Quality | 100 | Very Strong |
| Risk | 37 | Low |
| CEO | Christopher Simon |
| Headquarters | Boston, Massachusetts, United States |
| Founded | 1971 |
| Employees | 3.01K |
| P/E ratio | 44.55 |
| 52-week range | $47.32 – $91.39 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-03 | — | 1.3675 | — | $360.23M |
| 2026-11-04 | — | 1.303 | — | $348.34M |
| 2026-08-06 | — | 1.0876 | — | $331.17M |
| 2026-05-07 | 1.29 | 1.2846 | $346.35M | $340.23M |